References
- Alexandridis P, Holzwarth JF, Hatton TA. Micellization of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers in aqueous solutions: Thermodynamics of copolymer association. Macromolecules 1994; 27: 2414–25
- Bazile D, Prud'Homme C, Bassoullet MT, Marlard M, Spenlehauer G, Veillard M. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharma Sci 1995; 84: 493–8
- Blanco E, Kessinger CW, Sumer BD, Gao J. Multifunctional micellar nanomedicine for cancer therapy. Exp Biol Med (Maywood) 2009; 234: 123–31
- Burt HM, Zhang X, Toleikis P, Embree L, Hunter WL. Development of copolymers of poly(D,L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel. Colloids Surf B: Biointerfaces 1999; 16: 161–71
- Cai KY, Yao KD, Lin SB, Yang ZM, Li XQ, Xie HQ, Qing TW, Gao LB. Poly(D,L-lactic acid) surfaces modified by silk fibroin: Effects on the culture of osteoblast in vitro. Biomaterials 2002; 23: 1153–60
- Capranico G, Zunino F. DNA topoisomerase-trapping antitumour drugs. Eur J Cancer 1992; 28A: 2055–60
- Chen CH, Cuong NV, Chen YT, So RC, Liau I, Hsieh MF. Overcoming multidrug resistance of breast cancer cells by the micellar doxorubicin nanoparticles of mPEG-PCL-graft-cellulose. J Nanosci Nanotechnol 2011; 11: 53–6
- Cheon JB, Jeong YI, Cho CS. Effects of temperature on diblock copolymer micelle composed of poly(γ- benzyl L-glutamate) and poly(N-isopropylacrylamide). Polymer 1999; 40: 2041–50
- Chung TW, Tyan YC, Yang JD. PCP copolymers grafted with RGD enhance the rates of RGD-PCP micelles internalized into cells. J Microencapsul 2010; 27: 514–20
- Fritzsche H, Wähnert U, Chaires JB, Dattagupta N, Schlessinger FB, Crothers DM. Anthracycline antibiotics. Interaction with DNA and nucleosomes and inhibition of DNA synthesis. Biochemistry 1987; 26: 1996–2000
- Huang J, Bu L, Xie J, Chen K, Cheng Z, Li X, Chen X. Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano 2010; 4: 7151–60
- Husseini GA, Pitt WG. The use of ultrasound and micelles in cancer treatment. J Nanosci Nanotechnol 2008; 8: 2205–15
- Jain RK. Barriers to drug delivery in solid tumors. Sci Am 1994; 271: 58–65
- Jeong B, Kibbey MR, Birnbaum JC, Won YY, Gutowska A. Thermogelling biodegradable polymers with hydrophilic backbones: PEG-g-PLGA. Macromolecules 2000; 33: 8317–22
- Jette KK, Law D, Schmitt EA, Kwon GS. Preparation and drug loading of poly(ethylene glycol)-block-poly(ε-caprolactone) micelles through the evaporation of a cosolvent azeotrope. Pharma Res 2004; 21: 1184–91
- Kataoka K, Matsumoto T, Yokoyama M, Okano T, Sakurai Y, Fukushima S, Okamoto K, Kwon GS. Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: Their pharmaceutical characteristics and biological significance. J Control Release 2000; 64: 143–53
- Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Kim SW, Seo MH. In vivo evaluation of polymeric micellar paclitaxel formulation: Toxicity and efficacy. J Control Release 2001; 72: 191–202
- Lin YN, Alexandridis P. Self-assembly of an amphiphilic siloxane graft copolymer in water. J Phys Chem B 2002; 106: 10845–53
- Liu J, Zeng F, Allen C. In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration. Eur J Pharma Biopharma 2007; 65: 309–19
- Mahmud A, Xiong XB, Lavasanifar A. Development of novel polymeric micellar drug conjugates and nano-containers with hydrolyzable core structure for doxorubicin delivery. Eur J Pharma Biopharma 2008; 69: 923–34
- Makino K, Ohshima H, Kondo T. Mechanism of hydrolytic degradation of poly(L-lactide) microcapsules: Effects of pH, ionic strength and buffer concentration. J Microencapsul 1986; 3: 203–12
- Nasongkla N, Bey E, Ren J, Ai H, Khemtong C, Guthi JS, Chin SF, Sherry AD, Boothman DA, Gao J. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett 2006; 6: 2427–30
- Nasongkla N, Chen B, Macaraeg N, Fox ME, Frechet JMJ, Szoka FC. Dependence of pharmacokinetics and biodistribution on polymer architecture: Effect of cyclic versus linear polymers. J Am Chem Soc 2009; 131: 3842–3
- Nasongkla N, Shuai X, Ai H, Weinberg BD, Pink J, Boothman DA, Gao J. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew Chem – Int Edn 2004; 43: 6323–27
- Riley T, Stolnik S, Heald CR, Xiong CD, Garnett MC, Illum L, Davis SS, Purkiss SC, Barlow RJ, Gellert PR. Physicochemical evaluation of nanoparticles assembled from poly(lactic acid)-poly(ethylene glycol) (PLA-PEG) block copolymers as drug delivery vehicles. Langmuir 2001; 17: 3168–74
- Savic R, Luo L, Eisenberg A, Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 2003; 300: 615–8
- Scholz C, Ijjima M, Nagasaki Y, Kataoka K. A novel reactive polymeric micelle with aldehyde groups on its surface. Macromolecules 1995; 28: 7295–7
- Sharp JS, Forrest JA, Jones RAL. Swelling of poly(DL-lactide) and polylactide-co-glycolide in humid environments. Macromolecules 2001; 34: 8752–60
- Shuai X, Ai H, Nasongkla N, Kim S, Gao J. Micellar carriers based on block copolymers of poly(ε-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release 2004; 98: 415–26
- Sutton D, Nasongkla N, Blanco E, Gao J. Functionalized micellar systems for cancer targeted drug delivery. Pharma Res 2007a; 24: 1029–46
- Sutton D, Wang S, Nasongkla N, Gao J, Dormidontova EE. Doxorubicin and β-lapachone release and interaction with micellar core materials: Experiment and modeling. Exp Biol Med 2007b; 232: 1090–9
- Tang ZG, Black RA, Curran JM, Hunt JA, Rhodes NP, Williams DF. Surface properties and biocompatibility of solvent-cast poly[epsilon-caprolactone] films. Biomaterials 2004; 25: 4741–8
- Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 1984; 226: 466–8
- Verrecchia T, Spenlehauer G, Bazile DV, Murry-Brelier A, Archimbaud Y, Veillard M. Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers. J Control Release 1995; 36: 49–61
- Xu B, Yuan J, Wang Z, Gao Q. Shell-cross-linked amino acid-modified APLA-b-PEG-Cys copolymer micelle as a drug delivery carrier. J Microencapsul 2009; 26: 659–66
- Yamamoto Y, Nagasaki Y, Kato Y, Sugiyama Y, Kataoka K. Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge. J Control Release 2001; 77: 27–38
- Yasugi K, Nakamura T, Nagasaki Y, Kato M, Kataoka K. Sugar-installed polymer micelles: synthesis and micellization of poly(ethylene glycol)-poly(D,L-lactide) block copolymers having sugar groups at the PEG chain end. Macromolecules 1999; 32: 8024–32
- Yokoyama M, Okano T, Sakurai Y, Ekimoto H, Shibazaki C, Kataoka K. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res 1991; 51: 3229–36
- Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 1995; 55: 3752–6
- Yueying H, Yan Z, Chunhua G, Weifeng D, Meidong L. Micellar carrier based on methoxy poly(ethylene glycol)-block-poly(epsilon-caprolactone) block copolymers bearing ketone groups on the polyester block for doxorubicin delivery. J Mater Sci Mater Med 2010; 21: 567–74
- Zhang X, Jackson JK, Burt HM. Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int. J Pharma 1996; 132: 195–206